ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, PDPN, CD9, PRKCQ]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, NFKB1, CD36, TRAF1, PSMA6, IL1B, TLR4, LTF, TLR2, NLRC4, CD40LG]
GO:1902715;positive regulation of interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.8311634786251565;0.02521906460756386;0.8157270763441555;[CD2, CD244]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, CXADR, HOXB9, AGTR1, PRKCQ, S100A8, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, CCR10, CCR1, EGR3, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, CXCL12, NRP1, CXCL6, CXCL9, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR6, CCR5, CCR2, ANXA1, RHOG, GAB1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, PF4]
GO:2000318;positive regulation of T-helper 17 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.56398573135455;171.5773823021682;7.474488534686424;0.005742540576034618;0.7572456912631272;[NLRP3, PRKCQ]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CDA, ACPP, FBP1, HM13, SAMHD1, CD79A, CD247]
GO:0001865;NK T cell differentiation;8.0;1.0;0.875;9.628524252492122;92.19446145895849;8.67846133901236;0.0030856656554028718;0.8188169164668168;[ITK, BMX]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL1B, TLR8, TLR7, TLR4, HSPD1, KLRK1, IL12RB2, FZD5, CD2, HLA-DPB1, IL18R1, CD244]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, CD96, LILRB1, INHBA, PDCD1LG2, XCL1, TLR4, HAVCR2]
GO:0070207;protein homotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[ARG1, MGST1, MIF, TCL1A, CD247]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2C, AGTR1, FPR1, FPR2, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, HACE1, AZU1, ARHGAP6, DUSP1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, KCNH1, MSH6, MSH2, BLK, LY96, TNFRSF10B, BMX, CORO2A, NFKB1, LRRK2, TNFRSF1B, CCL5, CCL2, E2F7, SH2B1, IL2RB, TNFSF11, PAQR3, MIF, BTC, BTK, RACGAP1, CCR1, PTK2, RGL4, CD24, RGL1, BRCA2, CCR9, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, IL1B, KIT, PCNA, GNAI2, PAK1, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, DOK3, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, GH1, TNFAIP3, GHR, GRM5, NDUFS4, BCL2A1, EPS8L1, EGF, TEK, CYFIP1, EPS8, STMN1, ADCY9, LGALS12, PRKCQ, PLK2, ITK, CDKN1A, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, DGKZ, NRBP1, RAB32, MELK, CALCRL, DHCR24, BCL6, CNOT3, CSPG4, LAT, TREM1, CX3CR1, RAB21, PLN, DNAJA3, EDNRB, PPP2R1A, CHEK1, PTGDR, SIK1, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, RHOG, AVPR1A, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, SIPA1, SIRPG, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, NFKBIA, JMY, DOCK5, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, NCAM1, TSHR]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, TLR2]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[LRRK2, KLRK1, PDE6D]
GO:2000570;positive regulation of T-helper 2 cell activation;11.0;1.0;0.9324289523296623;9.628524252492122;326.26765218285163;9.777073627680469;0.010919884696736623;0.9324289523296623;[PRKCQ]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[TNF, AKT1, CD247]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, BLNK, TPD52, CR2, IFNA14, IFNA16, NFAM1, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, CD40LG, BCL6, FCGR2B, ITM2A]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[FCRL3, NFAM1, INHBA, BTK, CARD11]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, MEF2C, CR2, IFNA14, IFNA16, IFNA2, CD180, IFNA8, HSPD1, CD79A, CD40LG, MS4A1, CARD11, IFNA21, IFNA10]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[HMGB2, NFE2, MEF2C, PRKCQ, MYL9, PF4]
GO:0042267;natural killer cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;47.356962503066434;6.7325511899570465;0.001584994916478408;0.6674232935401965;[KLRK1, SLAMF7, KIR3DL1]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, PDCD1LG2, ZAP70, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CORO1A, HLA-DMB, CCL5, CCL19, LILRB2, CD4, CD40LG, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, TSC2, SLA2, PTPRE, IL1B, PRKCQ]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, CD3E, CCR9, CCR6, ANXA1, RUNX2, ZAP70, CLEC4D, KIT, BLM, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, BMX, CD4, DNAJA3, CD28, GPR18, IL18R1]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[CD83, SLC46A2, CD80, IFNA2, MYB, HLA-DOA, CR1, ANXA1, ZAP70, IFNG, IL1B, CARD11, CLPTM1, NLRP3, CCL19, TGFB1, EGR3, LILRB2, CD2, VNN1, BCL6, CAMK4, CD28]
GO:0002323;natural killer cell activation involved in immune response;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;81.35731265221925;6.641579411751319;0.0027229560376420305;0.6627709925721352;[IFNA5, IFNA4, IFNA7, IFNA14, IFNA16, IFNA2, IFNA8, CORO1A, CD244, IFNA21, IFNA10]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[CCT4, CCT2, GRHL2, PRKCQ]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, PPP2R1A, AKT1, AGTR1, PRKCQ, SFN, NRP1, CDKN1A, ESM1, AVPR1A, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, CDKN2C, SIPA1, SEMA5B, CTGF, CXCL16, TNR, S100A8, IGFBP7, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, TCHP, MYOCD, DCC, DNM2, PSRC1, NDUFS3, FBP1, TAF9, RAB21, SEMA4B]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, PRKCQ]
GO:0002769;natural killer cell inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;9.083926447120524;0.004356384815420379;0.839552420951524;[CLEC12B, KIR2DL1]
GO:0002728;negative regulation of natural killer cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;694.1135629292197;9.777073627680469;0.023231356289590815;0.896240625180289;[CD96]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, TFRC, TNFSF13B, MEF2C, FCRL3, MIF, MSH6, BST1, BCL6, CARD11, CD320]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, VRK1, PRKCQ, PLK2, LRRK2, MAP4K1, SGK1, CAMK4, PKN1]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[F2R, TLR1, CD2, PYCARD, FFAR2, CD58, CD244, TLR2]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[PRG2, CD3E, CD40LG, CD28, NLRP3, PRKCQ, HAVCR2]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[PTGS2, TNF, KLRK1, AKT1, CD36, AGXT2, DNM2, IFNG, IL1B, PTX3, TLR4]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[PRKCQ]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, LAT2, BTK, PRKCQ, CARD11, PAK1, IGKC, IGLV1-44, LYN, NFKB1, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[GOLT1B, TNF, AKT1, TNFSF11, F2R, CARD11, NDFIP2, PLK2, TNFRSF10B, CCDC22, FASLG, NUP62, CD36, ZDHHC17, IL1B, LTF, FLNA, CCL19, CARD9, CD4, LTBR]
GO:0046710;GDP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.574457031221845;1314.1926939491284;7.138016298065211;0.04398484676983994;0.7802794972956796;[MPP1, CARD11]
GO:0046037;GMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.548481544818586;1315.1089846810005;6.7325511899570465;0.04401551419602758;0.7595439928109722;[MPP1, PRTFDC1, CARD11]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, PAK1, IGKC, IGLV1-44, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD83, CD80, MYB, NLRP3, CCL19, ANXA1, ZAP70, IFNG]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[ICAM2, PAK1, KLRK1, MUC15, LYN, CARD9, NFKB1, CLEC4D, CARD11]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, TRAT1, ZAP70, P2RX5, CD4]
GO:0002534;cytokine production involved in inflammatory response;3.0;0.9326813400603323;0.6644609826203107;9.405380701177911;21.07076093796092;8.67846133901236;7.052194061398546E-4;0.6419372290569613;[CD96, SEH1L]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, CD3E, ZAP70, CD28, XCL1, CCR2]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, PRKCQ, LY9]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, CD3G, CD3E, GRAP2, PDE4B, ICOSLG, HLA-DPA1, ZAP70, BTK, PRKCQ, CARD11, HLA-DQB1, HHLA2, PAK1, HLA-DQA1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, CD28, HLA-DPB1, HLA-DRA, CD247, LAT]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, IGHA1, LYN, MEF2C, BMX, LAT2, BTK, IGHD]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, SLA2, MYB, C3AR1, UBASH3A, MEF2C, CXADR, PRKCQ, HHLA2, FPR1, FPR3, FPR2, KLRK1, S100A14, IGHA1, HLA-DQA1, ELANE, LYN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, DENND1B, ITK, SIGLEC9, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, NFAM1, PAWR, SERPINB9, PAX5, MMP12, FCER2, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, NR1H2, CARD9, KIR3DL1, HLA-DPB1, PKN1, CLC, LGR4, CXCL13, TNF, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4D, MSH2, S100A8, BLK, CD274, LY96, IGLV1-44, EIF2B3, BMX, NFKB1, BCL6, HLA-DRA, LAT, ITGAM, TREM2, TREM1, TNFSF13B, FCGR3A, CR2, CR1, PVRIG, XCL1, UNC93B1, NLRC4, CCL5, FCGR1B, FCGR2A, CD247, FCGR2B, CLEC2D, ICAM2, LGALS3, ICOSLG, SLC11A1, MIF, BTK, STXBP2, CD1E, CD1B, CD1A, CD79B, CD79A, CD19, SLAMF7, SH2D1A, PTK2, MARCO, CD28, CD24, CD200, IGHM, IFNA2, CD3G, CD3E, CTSS, FCER1A, FFAR2, CTSG, MUC15, CD36, CD33, CCR2, LAT2, TLR1, NCR1, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR5, TLR4, TLR2, PAK1, IGKC, NPDC1, LILRB1, LILRB2, MLH1, CD40LG, CD80, IL18RAP, IL6R, CD96, OSCAR, KLRF1, CD300C, CARD11, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, KIR2DL3, KIR2DL4, STAP1, NLRP3, TGFB1, CAV1, NFKBIA, KLRD1, IGKV3-20, HMGB2, TNFAIP3, PDE4B, ZAP70, IFNG, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, TRAT1, CD4]
GO:0038202;TORC1 signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.12151398160788;7.697632086000634;9.077326651865194E-4;0.7445766281117727;[CARD11]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, GRAP2, BTLA, AKT1, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CAV1, PDCD1LG2, CD40LG, CD28, CD24, CARD11]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, BTC, BTK, EPHA3, SDC2, TGFA, SLC30A10, FLRT2, PDGFD, PDGFC, LYN, PTK2, NRP1, ITK, PTPRR, NRP2, CD3E, GAB1, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, GRAP2, AP2M1, PDGFRB, TSC2, KIF16B, BLK, RASGRP4, FOXO1, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, CSPG4, GHR, BLNK, MMP9, ZAP70, ESRP1, REPS2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, CD4, CD7, TEK]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, C5AR1, AVPR1A, SELE, RASGRP4]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, SLA2, GRAP2, LYN, BMX, PTK2, ZAP70, BTK]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, C3AR1, AKT1, MEF2C, HHLA2, FPR1, FPR3, FPR2, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JAG1, HLA-DRB4, VANGL1, SIGLEC9, LRRC4, HLA-DPA1, PTH2R, LRRC19, PTAFR, KCNA5, PTGS2, NTF3, STAT4, FLNA, IL12RB2, P2RY13, P2RY14, USP9Y, TMEM64, HLA-DPB1, LGR4, NCF4, F13A1, CXCL13, CTGF, AP2M1, LAG3, IFNA14, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, TNFRSF17, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, LCN2, HLA-DRA, CIITA, ITGAM, ITGB4, LRRK2, FASLG, TNFSF13B, HHEX, FCGR3A, ITGB6, TNFRSF1B, ITGA7, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FCGR1B, TSPAN13, FCGR2A, IL2RB, CD247, FCGR2B, ICAM2, TNFSF11, EPHB1, MIF, BTC, BTK, EPHA3, SDC2, TGFA, CD19, TSPAN5, TSPAN2, CCR1, EGR1, TNFSF14, TNFSF12, PPBP, PTK2, CD28, SDC1, CD24, IGHM, NRP1, PTPRR, NRP2, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CCR9, FCER1A, CD37, CCR6, MUC15, CD36, CCR5, CCR2, GAB1, RGMA, LAT2, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, SORT1, IL18R1, IL17A, CD80, CELSR1, CCRL2, IL6R, PDGFRB, CD97, GEM, OSCAR, CCNE1, CARD11, PSEN2, KIR2DL1, RASGRP4, CAV2, CRIM1, INHBA, GH1, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, MMP9, BCL2A1, SAMHD1, EGF, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, EPS8, STMN1, GPR171, HOXB9, PRKCQ, FLRT2, IGHA1, HLA-DQA1, FZD5, CDK14, DENND1B, ITK, CDKN1A, ASGR2, ANXA1, NFAM1, AES, FCER2, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL20, CARD9, G0S2, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3R, PLXND1, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, TLE4, CLEC4D, ADAM9, CD151, CALCRL, IGLV1-44, EIF2B3, BCL6, CSPG4, LAT, CR2, CR1, ESRP1, XCL1, CX3CR1, P2RY6, PLN, P2RY2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, P2RX5, P2RX1, CLEC2D, EDNRB, ICOSLG, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, TLN1, PFN1, APCDD1, CD79B, CD79A, CCR10, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, GP1BB, GPBAR1, PDCD1LG2, IL17RB, CEACAM1, RHOU, TLR4, TLR2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, KRT19, CD40LG, IL18RAP, TSC2, KIF16B, KLRF1, PRTN3, C5AR1, CSF2RB, ADRB2, STAP1, TGFB1, NR4A2, NFKBIA, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, TGFBR3, ZAP70, IFNG, CLEC12B, DLL1, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, BTK, TLR8, TLR7, TLR4, CARD11, LY96, CARD9, NFKB1, NFKBIA]
GO:0060732;positive regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;800.1222801547256;7.212124270218933;0.026779372653476994;0.7438283705770736;[LHCGR, PTAFR, CD244]
GO:0045954;positive regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.31665099041965;6.444869117505266;0.014435780148864921;0.7258315315665724;[LAG3, SH2D1A, IL18RAP, KLRK1]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CXCL6, CXCL9, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, NFKB1, CXCL10, CXCL11, PF4]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[PSEN2, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0002228;natural killer cell mediated immunity;5.0;0.8436909121759173;0.712086467948879;9.446202695698167;40.18300418331115;6.641579411751319;0.001344888987659518;0.6298916918429109;[KIR3DL1, KLRK1, SLAMF7, KLRD1]
GO:0070970;interleukin-2 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[CARD11]
GO:0071663;positive regulation of granzyme B production;7.0;1.0;0.8509193652572005;9.628524252492122;91.76586570378727;9.083926447120524;0.0030713209411884286;0.8154717862087246;[XCL1, CD244]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, SLA2, LGALS3, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, LY9, KLRK1, SLAMF7, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, ARG1, TLR1, IGHD, TLR8, TLR10, TLR7, TLR5, TLR4, TLR2, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, LY96, CORO1A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, NFKB1, LCN2, KLRD1, ITGAM, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, ZAP70, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, CD6, PTX3, CD244]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, CCT6A, PRKCQ]
GO:0072678;T cell migration;7.0;0.7140352122741334;0.7079369713942671;8.8813098506619;30.235634434558513;6.686031174322154;0.001011959474220325;0.692843310444282;[CXCL9, GPR15, CCL20, DEFA1, CXCL16, CXCL10, ZAP70, CXCL11, CCL2, CCR6, CCR2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD80, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, ELANE, ABCA1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, CXCL10, CXCL11, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, CXCL3, CXCL2, CXCL5, ALAD, PDE4B, CTSG, CD36, CCR5, HAVCR2, PTGIR, ARG1, PDCD1LG2, TNFRSF1B, IL1B, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, GCH1, CCL20, NR1H2, LILRB1, LILRB2, CD6, LTBR, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, SIRPG, CXCL13, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, IGLV1-44, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB1, GPR15, CAV1, TNFRSF10B, AZU1, DEFA1, PPBP, SELE, CXCL10, CXCL11, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, CXCL1, SLC7A11, CXCL3, CXCL2, TREM1, CXCL5, PDE4B, OLR1, FFAR2, CCR6, CCR5, CCR2, ANXA1, MMP9, SLC7A5, ZAP70, CEACAM1, SLC7A7, SLC7A8, CEACAM6, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL20, CD2, NLRP12, TEK, CD244, PF4]
GO:2000502;negative regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1002.759017369874;9.083926447120524;0.03356144188684441;0.8969813732811862;[KLRK1, CCL2]
